Literature DB >> 15564462

Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001.

Hiroyuki Shimizu1, Bruce Thorley, Fem Julia Paladin, Kerri Anne Brussen, Vicki Stambos, Lilly Yuen, Andi Utama, Yoshio Tano, Minetaro Arita, Hiromu Yoshida, Tetsuo Yoneyama, Agnes Benegas, Sigrun Roesel, Mark Pallansch, Olen Kew, Tatsuo Miyamura.   

Abstract

In 2001, highly evolved type 1 circulating vaccine-derived poliovirus (cVDPV) was isolated from three acute flaccid paralysis patients and one contact from three separate communities in the Philippines. Complete genomic sequencing of these four cVDPV isolates revealed that the capsid region was derived from the Sabin 1 vaccine strain but most of the noncapsid region was derived from an unidentified enterovirus unrelated to the oral poliovirus vaccine (OPV) strains. The sequences of the cVDPV isolates were closely related to each other, and the isolates had a common recombination site. Most of the genetic and biological properties of the cVDPV isolates were indistinguishable from those of wild polioviruses. However, the most recently identified cVDPV isolate from a healthy contact retained the temperature sensitivity and partial attenuation phenotypes. The sequence relationships among the isolates and Sabin 1 suggested that cVDPV originated from an OPV dose given in 1998 to 1999 and that cVDPV circulated along a narrow chain of transmission. Type 1 cVDPV was last detected in the Philippines in September 2001, and population immunity to polio was raised by extensive OPV campaigns in late 2001 and early 2002.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15564462      PMCID: PMC533948          DOI: 10.1128/JVI.78.24.13512-13521.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  61 in total

1.  Genetic analysis of wild polioviruses towards the eradication of poliomyelitis from the Western Pacific Region.

Authors:  A Hagiwara; T Yoneyama; K Yoshii; H Yoshida; H Shimizu; J Wada; N T Thanh; P Van Tu; T Miyamura
Journal:  Jpn J Infect Dis       Date:  1999-08       Impact factor: 1.362

2.  Eradication of poliomyelitis.

Authors:  Akio Nomoto; Isao Arita
Journal:  Nat Immunol       Date:  2002-03       Impact factor: 25.606

3.  Natural genetic recombination between co-circulating heterotypic enteroviruses.

Authors:  Gabriela Oprisan; Mariana Combiescu; Sophie Guillot; Valerie Caro; Andrei Combiescu; Francis Delpeyroux; Radu Crainic
Journal:  J Gen Virol       Date:  2002-09       Impact factor: 3.891

4.  Progress towards global eradication of poliomyelitis, 2002.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2003-04-25

5.  Isolation of an intertypic poliovirus capsid recombinant from a child with vaccine-associated paralytic poliomyelitis.

Authors:  Javier Martín; Elena Samoilovich; Glynis Dunn; Angie Lackenby; Esphir Feldman; Alan Heath; Ekaterina Svirchevskaya; Gill Cooper; Marina Yermalovich; Philip D Minor
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

6.  Isolation of vaccine-derived type 1 polioviruses displaying similar properties to virulent wild strain Mahoney from sewage in Japan.

Authors:  Hitoshi Horie; Hiromu Yoshida; Kumiko Matsuura; Miwako Miyazawa; Kengo Wakabayashi; Akio Nomoto; So Hashizume
Journal:  J Med Virol       Date:  2002-11       Impact factor: 2.327

7.  Laboratory surveillance for wild poliovirus and vaccine-derived poliovirus, 2000-2001.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2002-05-03       Impact factor: 17.586

8.  Characterization of a recombinant type 3/type 2 poliovirus isolated from a healthy vaccinee and containing a chimeric capsid protein VP1.

Authors:  Soile Blomqvist; Anne-Lise Bruu; Mirja Stenvik; Tapani Hovi
Journal:  J Gen Virol       Date:  2003-03       Impact factor: 3.891

9.  Evolution of the genome of Human enterovirus B: incongruence between phylogenies of the VP1 and 3CD regions indicates frequent recombination within the species.

Authors:  A Michael Lindberg; Per Andersson; Carita Savolainen; Mick N Mulders; Tapani Hovi
Journal:  J Gen Virol       Date:  2003-05       Impact factor: 3.891

10.  Long-term circulation of vaccine-derived poliovirus that causes paralytic disease.

Authors:  Elena A Cherkasova; Ekaterina A Korotkova; Maria L Yakovenko; Olga E Ivanova; Tatyana P Eremeeva; Konstantin M Chumakov; Vadim I Agol
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

View more
  58 in total

1.  Multiplex PCR method for identifying recombinant vaccine-related polioviruses.

Authors:  David R Kilpatrick; Karen Ching; Jane Iber; Ray Campagnoli; Christopher J Freeman; Nada Mishrik; Hong-Mei Liu; Mark A Pallansch; Olen M Kew
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

2.  A Sabin 3-derived poliovirus recombinant contained a sequence homologous with indigenous human enterovirus species C in the viral polymerase coding region.

Authors:  Minetaro Arita; Shuang-Li Zhu; Hiromu Yoshida; Tetsuo Yoneyama; Tatsuo Miyamura; Hiroyuki Shimizu
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

3.  Use of a multiple restriction fragment length polymorphism method for detecting vaccine-derived polioviruses in clinical samples.

Authors:  Natalia I Romanenkova; Sophie Guillot; Nadejda R Rozaeva; Radu Crainic; Maina A Bichurina; Francis Delpeyroux
Journal:  J Clin Microbiol       Date:  2006-09-06       Impact factor: 5.948

4.  Retrospective characterization of a vaccine-derived poliovirus type 1 isolate from sewage in Greece.

Authors:  Evaggelos Dedepsidis; Zaharoula Kyriakopoulou; Vaia Pliaka; Christine Kottaridi; Eugenia Bolanaki; Stamatina Levidiotou-Stefanou; Dimitri Komiotis; Panayotis Markoulatos
Journal:  Appl Environ Microbiol       Date:  2007-09-07       Impact factor: 4.792

5.  Calibration of multiple poliovirus molecular clocks covering an extended evolutionary range.

Authors:  Jaume Jorba; Ray Campagnoli; Lina De; Olen Kew
Journal:  J Virol       Date:  2008-02-20       Impact factor: 5.103

6.  Limited and localized outbreak of newly emergent type 2 vaccine-derived poliovirus in Sichuan, China.

Authors:  Dongmei Yan; Yong Zhang; Shuangli Zhu; Na Chen; Xiaolei Li; Dongyan Wang; Xiaozhen Ma; Hui Zhu; Wenbin Tong; Wenbo Xu
Journal:  Clin Vaccine Immunol       Date:  2014-05-21

7.  Impact of exogenous sequences on the characteristics of an epidemic type 2 recombinant vaccine-derived poliovirus.

Authors:  Franck B Riquet; Claire Blanchard; Sophie Jegouic; Jean Balanant; Sophie Guillot; Marie-Anne Vibet; Mala Rakoto-Andrianarivelo; Francis Delpeyroux
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

8.  Reemergence of enterovirus 71 in 2008 in taiwan: dynamics of genetic and antigenic evolution from 1998 to 2008.

Authors:  Sheng-Wen Huang; Yun-Wei Hsu; Derek J Smith; David Kiang; Huey-Pin Tsai; Kuei-Hsiang Lin; Shih-Min Wang; Ching-Chung Liu; Ih-Jen Su; Jen-Ren Wang
Journal:  J Clin Microbiol       Date:  2009-09-23       Impact factor: 5.948

9.  Identification of vaccine-derived polioviruses using dual-stage real-time RT-PCR.

Authors:  David R Kilpatrick; Karen Ching; Jane Iber; Qi Chen; Su-Ju Yang; Lina De; A J Williams; Mark Mandelbaum; Hong Sun; M Steven Oberste; Olen M Kew
Journal:  J Virol Methods       Date:  2013-12-07       Impact factor: 2.014

10.  High frequency and diversity of species C enteroviruses in Cameroon and neighboring countries.

Authors:  Serge Alain Sadeuh-Mba; Maël Bessaud; Denis Massenet; Marie-Line Joffret; Marie-Claire Endegue; Richard Njouom; Jean-Marc Reynes; Dominique Rousset; Francis Delpeyroux
Journal:  J Clin Microbiol       Date:  2012-12-19       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.